Intelicare Holdings Limited (ASX:ICR)
0.0250
-0.0010 (-3.85%)
At close: Dec 5, 2025
Intelicare Holdings Revenue
In the fiscal year ending June 30, 2025, Intelicare Holdings had annual revenue of 956.74K AUD with 236.75% growth. Intelicare Holdings had revenue of 455.75K in the half year ending June 30, 2025, with 76.90% growth.
Revenue
956.74K
Revenue Growth
+236.75%
P/S Ratio
15.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 956.74K | 672.63K | 236.75% |
| Jun 30, 2024 | 284.11K | -126.10K | -30.74% |
| Jun 30, 2023 | 410.21K | -77.11K | -15.82% |
| Jun 30, 2022 | 487.32K | 115.11K | 30.92% |
| Jun 30, 2021 | 372.22K | 104.68K | 39.13% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |